| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | antiporter activity | 1.35e-06 | 138 | 115 | 8 | GO:0015297 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR1S1 OR1S2 LMBR1 GPR87 TNFRSF18 CCKAR OR4L1 OR4C3 TAS2R8 OR4S1 CELSR3 LMBR1L TAS2R33 TAS1R2 SCTR HRH2 C3AR1 ROS1 FGFR2 OR4F21 GRIN3B OR4K3 | 8.19e-06 | 1353 | 115 | 22 | GO:0004888 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA2D1 PSG5 PSG6 SLC43A3 TMEM38B MFSD12 SLC41A2 SLC9A2 SLC9A3 CLCN5 SLC19A1 KCNMA1 SLC35F6 OTOP1 SLC35E3 GRIN3B SLC41A1 SLC4A9 SLC4A11 | 4.25e-05 | 1180 | 115 | 19 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CACNA2D1 PSG5 PSG6 SLC43A3 TMEM38B MFSD12 SLC41A2 SLC9A2 SLC9A3 CLCN5 TMEM184A SLC19A1 KCNMA1 SLC35F6 OTOP1 SLC35E3 GRIN3B SLC41A1 SLC4A9 SLC4A11 | 4.38e-05 | 1289 | 115 | 20 | GO:0005215 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR1S1 OR1S2 GPR87 CCKAR OR4L1 OR4C3 TAS2R8 OR4S1 CELSR3 TAS2R33 TAS1R2 SCTR HRH2 C3AR1 OR4F21 OR4K3 | 4.68e-05 | 884 | 115 | 16 | GO:0004930 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | MFSD12 SLC9A2 SLC9A3 CLCN5 SLC19A1 SLC35E3 SLC41A1 SLC4A9 SLC4A11 | 5.45e-05 | 296 | 115 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.08e-04 | 43 | 115 | 4 | GO:0140828 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 2.97e-04 | 293 | 115 | 8 | GO:0008514 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA2D1 TMEM38B SLC41A2 SLC9A2 SLC9A3 KCNMA1 GRIN3B SLC41A1 SLC4A9 SLC4A11 | 3.59e-04 | 465 | 115 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA2D1 TMEM38B SLC41A2 SLC9A2 SLC9A3 CLCN5 SLC19A1 KCNMA1 OTOP1 GRIN3B SLC41A1 SLC4A9 SLC4A11 | 6.48e-04 | 793 | 115 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | antigen binding | 8.18e-04 | 190 | 115 | 6 | GO:0003823 | |
| GeneOntologyMolecularFunction | taste receptor activity | 8.95e-04 | 33 | 115 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA2D1 TMEM38B SLC41A2 SLC9A2 SLC9A3 KCNMA1 OTOP1 GRIN3B SLC41A1 SLC4A9 SLC4A11 | 9.95e-04 | 627 | 115 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.27e-03 | 207 | 115 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.30e-03 | 208 | 115 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA2D1 TMEM38B SLC41A2 SLC9A2 SLC9A3 CLCN5 KCNMA1 OTOP1 GRIN3B SLC41A1 SLC4A9 SLC4A11 | 1.42e-03 | 758 | 115 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA2D1 TMEM38B SLC41A2 SLC9A2 SLC9A3 KCNMA1 OTOP1 GRIN3B SLC41A1 SLC4A9 SLC4A11 | 1.57e-03 | 664 | 115 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | MFSD12 SLC9A2 SLC9A3 CLCN5 SLC19A1 SLC35E3 SLC41A1 SLC4A9 SLC4A11 | 1.77e-03 | 477 | 115 | 9 | GO:0022804 |
| GeneOntologyBiologicalProcess | immunoglobulin production | GPI IGLV6-57 NOD2 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 IGKV5-2 | 9.65e-06 | 241 | 117 | 9 | GO:0002377 |
| GeneOntologyCellularComponent | basal plasma membrane | PSG5 PSG6 SLC43A3 NOD2 DST SLC19A1 PLEC SLC41A1 SLC4A9 SLC4A11 | 3.06e-05 | 354 | 117 | 10 | GO:0009925 |
| GeneOntologyCellularComponent | immunoglobulin complex | IGLV6-57 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 IGKV5-2 | 4.18e-05 | 166 | 117 | 7 | GO:0019814 |
| GeneOntologyCellularComponent | basal part of cell | PSG5 PSG6 SLC43A3 NOD2 DST SLC19A1 PLEC SLC41A1 SLC4A9 SLC4A11 | 5.32e-05 | 378 | 117 | 10 | GO:0045178 |
| GeneOntologyCellularComponent | apical part of cell | FAT4 PSG5 PSG6 SLC9A2 SLC9A3 CLCN5 SLC19A1 PKHD1 KCNMA1 PLEC SLC4A9 SLC4A11 | 1.22e-04 | 592 | 117 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 4.44e-04 | 320 | 117 | 8 | GO:0016323 | |
| GeneOntologyCellularComponent | sarcoplasm | 4.55e-04 | 114 | 117 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 9.66e-04 | 78 | 117 | 4 | GO:0048787 | |
| MousePheno | abnormal renal reabsorption | 1.74e-06 | 35 | 82 | 5 | MP:0010107 | |
| Domain | LIMR | 3.13e-05 | 2 | 105 | 2 | IPR008075 | |
| Domain | - | 9.36e-05 | 3 | 105 | 2 | 1.10.357.20 | |
| Domain | MgtE | 9.36e-05 | 3 | 105 | 2 | PF01769 | |
| Domain | SLC41_membr_dom | 9.36e-05 | 3 | 105 | 2 | IPR006667 | |
| Domain | LMBR1 | 1.86e-04 | 4 | 105 | 2 | PF04791 | |
| Domain | LMBR1-like_membr_prot | 1.86e-04 | 4 | 105 | 2 | IPR006876 | |
| Domain | Actinin_actin-bd_CS | 2.82e-04 | 23 | 105 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 2.82e-04 | 23 | 105 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.82e-04 | 23 | 105 | 3 | PS00019 | |
| Domain | - | 4.63e-04 | 6 | 105 | 2 | 3.90.1290.10 | |
| Domain | Spectrin_repeat | 5.67e-04 | 29 | 105 | 3 | IPR002017 | |
| Domain | Plectin_repeat | 6.45e-04 | 7 | 105 | 2 | IPR001101 | |
| Domain | Plectin | 6.45e-04 | 7 | 105 | 2 | PF00681 | |
| Domain | PLEC | 6.45e-04 | 7 | 105 | 2 | SM00250 | |
| Domain | Spectrin/alpha-actinin | 7.61e-04 | 32 | 105 | 3 | IPR018159 | |
| Domain | SPEC | 7.61e-04 | 32 | 105 | 3 | SM00150 | |
| Domain | NaH_exchanger | 1.10e-03 | 9 | 105 | 2 | IPR004709 | |
| Domain | LAM_G_DOMAIN | 1.26e-03 | 38 | 105 | 3 | PS50025 | |
| Domain | GPCR_Rhodpsn_7TM | OR1S1 OR1S2 GPR87 CCKAR OR4L1 OR4C3 TAS2R8 OR4S1 HRH2 C3AR1 OR4F21 | 1.37e-03 | 670 | 105 | 11 | IPR017452 |
| Domain | HCO3_cotransp | 1.37e-03 | 10 | 105 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 1.37e-03 | 10 | 105 | 2 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 1.37e-03 | 10 | 105 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.37e-03 | 10 | 105 | 2 | IPR003020 | |
| Domain | Laminin_G_2 | 1.47e-03 | 40 | 105 | 3 | PF02210 | |
| Domain | Cation/H_exchanger_CPA1 | 1.67e-03 | 11 | 105 | 2 | IPR018422 | |
| Domain | G_PROTEIN_RECEP_F1_2 | OR1S1 OR1S2 GPR87 CCKAR OR4L1 OR4C3 TAS2R8 OR4S1 HRH2 C3AR1 OR4F21 | 1.74e-03 | 691 | 105 | 11 | PS50262 |
| Domain | GPCR_Rhodpsn | OR1S1 OR1S2 GPR87 CCKAR OR4L1 OR4C3 TAS2R8 OR4S1 HRH2 C3AR1 OR4F21 | 1.76e-03 | 692 | 105 | 11 | IPR000276 |
| Domain | LamG | 1.93e-03 | 44 | 105 | 3 | SM00282 | |
| Domain | Na_H_Exchanger | 2.73e-03 | 14 | 105 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 2.73e-03 | 14 | 105 | 2 | IPR006153 | |
| Domain | Laminin_G | 4.26e-03 | 58 | 105 | 3 | IPR001791 | |
| Domain | 7tm_1 | 4.79e-03 | 677 | 105 | 10 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 5.20e-03 | 685 | 105 | 10 | PS00237 | |
| Domain | CH | 5.86e-03 | 65 | 105 | 3 | SM00033 | |
| Domain | FA58C | 6.13e-03 | 21 | 105 | 2 | SM00231 | |
| Domain | FA58C_3 | 6.13e-03 | 21 | 105 | 2 | PS50022 | |
| Domain | FA58C_1 | 6.13e-03 | 21 | 105 | 2 | PS01285 | |
| Domain | FA58C_2 | 6.13e-03 | 21 | 105 | 2 | PS01286 | |
| Domain | Quino_amine_DH_bsu | 6.72e-03 | 22 | 105 | 2 | IPR011044 | |
| Domain | CH | 7.19e-03 | 70 | 105 | 3 | PF00307 | |
| Domain | Spectrin | 7.33e-03 | 23 | 105 | 2 | PF00435 | |
| Domain | - | 7.48e-03 | 71 | 105 | 3 | 1.10.418.10 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 1.27e-06 | 95 | 82 | 7 | M29842 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 1.38e-06 | 61 | 82 | 6 | M27581 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | PSG5 PSG6 PSG7 IGLV6-57 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40 IGKV5-2 | 1.81e-06 | 194 | 82 | 9 | M16312 |
| Pathway | REACTOME_FCGR_ACTIVATION | 2.88e-06 | 69 | 82 | 6 | M27108 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 2.88e-06 | 69 | 82 | 6 | M27150 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 3.41e-06 | 71 | 82 | 6 | M1078 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 3.41e-06 | 71 | 82 | 6 | M27203 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 4.59e-06 | 115 | 82 | 7 | M19752 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 6.86e-06 | 80 | 82 | 6 | M6121 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 7.92e-06 | 82 | 82 | 6 | M27110 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.04e-05 | 86 | 82 | 6 | M601 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 1.04e-05 | 86 | 82 | 6 | M27206 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 1.12e-05 | 87 | 82 | 6 | M27205 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 1.26e-05 | 134 | 82 | 7 | M29840 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 2.21e-05 | 98 | 82 | 6 | M27152 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | IGLV6-57 ADCY6 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40 C3AR1 IGKV5-2 | 3.97e-05 | 219 | 82 | 8 | M29836 |
| Pathway | REACTOME_PARASITE_INFECTION | 5.74e-05 | 116 | 82 | 6 | M29843 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 1.39e-04 | 136 | 82 | 6 | M27207 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 1.82e-04 | 143 | 82 | 6 | M27107 | |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 2.72e-04 | 154 | 82 | 6 | M39007 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 4.07e-04 | 166 | 82 | 6 | M608 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 7.43e-04 | 186 | 82 | 6 | M27175 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 8.30e-04 | 190 | 82 | 6 | M8240 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR1S1 OR1S2 OR4L1 OR4C3 TAS2R8 OR4S1 KCNMA1 TAS1R2 OTOP1 OR4F21 OR4K3 | 1.10e-03 | 636 | 82 | 11 | M41834 |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 1.17e-03 | 9 | 82 | 2 | M27337 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 1.17e-03 | 9 | 82 | 2 | MM15079 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 1.17e-03 | 9 | 82 | 2 | MM15117 | |
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 1.32e-06 | 7 | 118 | 3 | 7794280 | |
| Pubmed | One-megabase sequence analysis of the human immunoglobulin lambda gene locus. | 2.04e-06 | 109 | 118 | 6 | 9074928 | |
| Pubmed | 2.11e-06 | 8 | 118 | 3 | 1690992 | ||
| Pubmed | Nuclear membrane proteins with potential disease links found by subtractive proteomics. | 4.49e-06 | 10 | 118 | 3 | 12958361 | |
| Pubmed | NHE2-mediated bicarbonate reabsorption in the distal tubule of NHE3 null mice. | 1.14e-05 | 2 | 118 | 2 | 15604231 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 11705743 | ||
| Pubmed | BK Potassium Channels Suppress Cavα2δ Subunit Function to Reduce Inflammatory and Neuropathic Pain. | 1.14e-05 | 2 | 118 | 2 | 29466724 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 9502765 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 11960774 | ||
| Pubmed | Renal salt wasting in mice lacking NHE3 Na+/H+ exchanger but not in mice lacking NHE2. | 1.14e-05 | 2 | 118 | 2 | 11553519 | |
| Pubmed | Novel amiloride-sensitive sodium-dependent proton secretion in the mouse proximal convoluted tubule. | 1.14e-05 | 2 | 118 | 2 | 10772659 | |
| Pubmed | Intestinal brush-border Na+/H+ exchanger-3 drives H+-coupled iron absorption in the mouse. | 1.14e-05 | 2 | 118 | 2 | 27390324 | |
| Pubmed | Chloride channel (Clc)-5 is necessary for exocytic trafficking of Na+/H+ exchanger 3 (NHE3). | 1.14e-05 | 2 | 118 | 2 | 21561868 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 18383508 | ||
| Pubmed | Human BTR1, a new bicarbonate transporter superfamily member and human AE4 from kidney. | 1.14e-05 | 2 | 118 | 2 | 11302728 | |
| Pubmed | Intestinal distribution of human Na+/H+ exchanger isoforms NHE-1, NHE-2, and NHE-3 mRNA. | 1.14e-05 | 2 | 118 | 2 | 8843774 | |
| Pubmed | HCO3- salvage mechanisms in the submandibular gland acinar and duct cells. | 1.14e-05 | 2 | 118 | 2 | 11139574 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 11408268 | ||
| Pubmed | 1.68e-05 | 15 | 118 | 3 | 6101098 | ||
| Pubmed | 2.06e-05 | 16 | 118 | 3 | 23123061 | ||
| Pubmed | Sequence and evolution of the human germline V lambda repertoire. | 2.37e-05 | 49 | 118 | 4 | 8951372 | |
| Pubmed | 2.50e-05 | 17 | 118 | 3 | 7851895 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 19136951 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 14962844 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 19932097 | ||
| Pubmed | LMBRD1: the gene for the cblF defect of vitamin B₁₂ metabolism. | 3.42e-05 | 3 | 118 | 2 | 20446115 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 21252044 | ||
| Pubmed | Critical role for NHE1 in intracellular pH regulation in pancreatic acinar cells. | 3.42e-05 | 3 | 118 | 2 | 12842825 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 11876253 | ||
| Pubmed | Activation of fibroblast growth factor (FGF) receptors by recombinant human FGF-5. | 3.42e-05 | 3 | 118 | 2 | 8386828 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 12810078 | ||
| Pubmed | Interferon-gamma suppresses Na+ -H+ exchanger in cultured human endolymphatic sac epithelial cells. | 3.42e-05 | 3 | 118 | 2 | 19479940 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 19056765 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 16690903 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 11358967 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 19389806 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 10506152 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | CACNA2D1 FAT4 TMEM161B SLC43A3 CAV2 TMEM38B DMXL1 ERG28 NDC1 CELSR3 LPCAT3 TMEM245 RNFT1 CPSF1 | 5.87e-05 | 1201 | 118 | 14 | 35696571 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | GPI RETREG2 SAMD8 CAV2 ADCY6 INTS5 NDC1 TMEM168 APH1A LPCAT3 SLC35F6 ALG8 SGSM3 | 6.66e-05 | 1061 | 118 | 13 | 33845483 |
| Pubmed | Cftr and ENaC ion channels mediate NaCl absorption in the mouse submandibular gland. | 6.82e-05 | 4 | 118 | 2 | 20026617 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 10666043 | ||
| Pubmed | Molecular characterization of the human immunoglobulin V lambda I germline gene repertoire. | 6.82e-05 | 4 | 118 | 2 | 1495496 | |
| Pubmed | Genetic and age related models of neurodegeneration in mice: dystrophic axons. | 6.82e-05 | 4 | 118 | 2 | 1634998 | |
| Pubmed | Role of binding of plectin to the integrin beta4 subunit in the assembly of hemidesmosomes. | 6.82e-05 | 4 | 118 | 2 | 14668477 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 10841524 | ||
| Pubmed | Contributions of Na+/H+ exchanger isoforms to preimplantation development of the mouse. | 6.82e-05 | 4 | 118 | 2 | 9590530 | |
| Pubmed | 8.93e-05 | 212 | 118 | 6 | 19521566 | ||
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 24233434 | ||
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 2377620 | ||
| Pubmed | A calcineurin homologous protein inhibits GTPase-stimulated Na-H exchange. | 1.13e-04 | 5 | 118 | 2 | 8901634 | |
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 10318855 | ||
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 18003792 | ||
| Pubmed | 1.14e-04 | 430 | 118 | 8 | 16303743 | ||
| Pubmed | 1.17e-04 | 28 | 118 | 3 | 8672132 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 8903721 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 24018950 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 10666041 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 15703204 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 18827015 | ||
| Pubmed | 1.76e-04 | 32 | 118 | 3 | 24954895 | ||
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 12576672 | ||
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 10637308 | ||
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 23677982 | ||
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 23665963 | ||
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 2537643 | ||
| Pubmed | A ciliopathy complex at the transition zone protects the cilia as a privileged membrane domain. | 2.95e-04 | 38 | 118 | 3 | 22179047 | |
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 28087565 | ||
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 20301543 | ||
| Pubmed | 4.05e-04 | 9 | 118 | 2 | 12482924 | ||
| Pubmed | Familial pure proximal renal tubular acidosis--a clinical and genetic study. | 4.05e-04 | 9 | 118 | 2 | 17881426 | |
| Pubmed | Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle. | 4.05e-04 | 9 | 118 | 2 | 15905575 | |
| Pubmed | 4.05e-04 | 9 | 118 | 2 | 8026341 | ||
| Pubmed | Interleukin-10-deficient mice develop chronic enterocolitis. | 4.05e-04 | 9 | 118 | 2 | 8402911 | |
| Pubmed | 4.05e-04 | 9 | 118 | 2 | 22683701 | ||
| Pubmed | 4.26e-04 | 43 | 118 | 3 | 1249422 | ||
| Pubmed | 5.05e-04 | 10 | 118 | 2 | 1697263 | ||
| Pubmed | Human Ccr4-Not complex is a ligand-dependent repressor of nuclear receptor-mediated transcription. | 5.05e-04 | 10 | 118 | 2 | 16778766 | |
| Pubmed | 5.05e-04 | 10 | 118 | 2 | 11747081 | ||
| Pubmed | 5.54e-04 | 47 | 118 | 3 | 814163 | ||
| Pubmed | 5.54e-04 | 47 | 118 | 3 | 11208732 | ||
| Pubmed | 5.89e-04 | 48 | 118 | 3 | 11955599 | ||
| Pubmed | 6.15e-04 | 11 | 118 | 2 | 8901049 | ||
| Pubmed | 6.15e-04 | 11 | 118 | 2 | 18199118 | ||
| Pubmed | 6.15e-04 | 11 | 118 | 2 | 12802069 | ||
| Pubmed | 6.15e-04 | 11 | 118 | 2 | 10811835 | ||
| Pubmed | Current insights into the formation and breakdown of hemidesmosomes. | 6.15e-04 | 11 | 118 | 2 | 16757171 | |
| Pubmed | Fibroblast-growth-factor receptor mutations in human skeletal disorders. | 7.37e-04 | 12 | 118 | 2 | 8585128 | |
| Pubmed | 7.37e-04 | 12 | 118 | 2 | 28595999 | ||
| Pubmed | 7.37e-04 | 12 | 118 | 2 | 12748966 | ||
| Pubmed | 8.32e-04 | 54 | 118 | 3 | 8482578 | ||
| Pubmed | 8.69e-04 | 13 | 118 | 2 | 9385055 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 8.69e-04 | 13 | 118 | 2 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 8.69e-04 | 13 | 118 | 2 | 1985902 | |
| Pubmed | 8.69e-04 | 13 | 118 | 2 | 10964771 | ||
| Pubmed | 8.69e-04 | 13 | 118 | 2 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 8.69e-04 | 13 | 118 | 2 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 8.69e-04 | 13 | 118 | 2 | 16638824 | |
| Pubmed | 8.69e-04 | 13 | 118 | 2 | 20044046 | ||
| Pubmed | 8.69e-04 | 13 | 118 | 2 | 32150576 | ||
| Pubmed | 8.69e-04 | 13 | 118 | 2 | 22469976 | ||
| Interaction | YIPF3 interactions | 5.62e-07 | 186 | 105 | 9 | int:YIPF3 | |
| Interaction | CRELD1 interactions | 2.33e-05 | 163 | 105 | 7 | int:CRELD1 | |
| Cytoband | 22q11.2 | 6.94e-07 | 120 | 117 | 6 | 22q11.2 | |
| Cytoband | 7q21-q22 | 2.86e-04 | 10 | 117 | 2 | 7q21-q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 7.44e-04 | 419 | 117 | 6 | chr22q11 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | 2.32e-06 | 89 | 78 | 6 | 353 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.24e-05 | 11 | 78 | 3 | 1315 | |
| GeneFamily | Solute carriers | SLC43A3 SLC41A2 SLC9A2 SLC9A3 SLC19A1 SLC35E3 SLC41A1 SLC4A9 SLC4A11 | 4.99e-05 | 395 | 78 | 9 | 752 |
| GeneFamily | Olfactory receptors, family 4 | 2.38e-04 | 129 | 78 | 5 | 151 | |
| GeneFamily | EF-hand domain containing|Plakins | 5.06e-04 | 8 | 78 | 2 | 939 | |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | TNFRSF18 IGLV6-57 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 | 7.88e-07 | 196 | 115 | 7 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda |
| ToppCell | TCGA-Lung|World / Sample_Type by Project: Shred V9 | 2.59e-06 | 150 | 115 | 6 | 8c133206786e8f22bb70f2a7de9c0cb7f9ea9313 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.16e-06 | 179 | 115 | 6 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.40e-06 | 180 | 115 | 6 | cea079bc02e08c46600eed05ab9924ec90e1e3d3 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.88e-06 | 182 | 115 | 6 | 1bf2e4fd6222b41a7d08df6dcc500c9401db8c18 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.13e-06 | 183 | 115 | 6 | cf5c98f451a568308c52da5c926543dd4836c6b2 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.65e-06 | 185 | 115 | 6 | 6ec009e48e50471c28e914c402f500e56a88f8f2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-06 | 185 | 115 | 6 | 0fff2608f507e019ebb69c27e58fd5be3b049bef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-06 | 185 | 115 | 6 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.65e-06 | 185 | 115 | 6 | f49ad6401b2abd089e30eba245b11b5031ea2318 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-06 | 188 | 115 | 6 | 315ce1736e3a84a63a8d5dfa70d411b501cb2532 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 190 | 115 | 6 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 190 | 115 | 6 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-05 | 191 | 115 | 6 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.10e-05 | 193 | 115 | 6 | 7839040e703877ef321494ad8926a8604729ceda | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 194 | 115 | 6 | f083777353e76a2d9c39f8b6cb1a689b68b81c56 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.17e-05 | 195 | 115 | 6 | eb809331557f8c40de45b1208cbc49b621930a4b | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 196 | 115 | 6 | c5adc95df9e1d1884a7988336e459a98c5a6769b | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 196 | 115 | 6 | 81d1fd63397b2cf893607d828b61a926fa65185f | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.24e-05 | 197 | 115 | 6 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb | |
| ToppCell | BAL-Severe-Myeloid-cDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-05 | 199 | 115 | 6 | 0b20ae65b9340d844e271acda9e116d98fc1cc69 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-05 | 199 | 115 | 6 | bb9e7418468b88cdfaa78788d062362794ea8230 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-05 | 199 | 115 | 6 | 9a0e853693e572c63b135f937b2cffd4dd4026fb | |
| ToppCell | Severe_COVID-19-Myeloid-cDC|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.31e-05 | 199 | 115 | 6 | 9132c1929d3445fcca49f76f010ca37adeb70315 | |
| ToppCell | BAL-Severe-Myeloid-cDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-05 | 199 | 115 | 6 | d017848256704ae7237030868b143c3f0842a9c3 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor|TCGA-Testes / Sample_Type by Project: Shred V9 | 2.96e-05 | 138 | 115 | 5 | f7c40156c34d2d910bbda5ba07540ad0f6f22981 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.06e-05 | 139 | 115 | 5 | 34398a6f21a1e670497655a7bb7f3cde9e117560 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.06e-05 | 139 | 115 | 5 | 450c4152c9fe4ec503271bb3cf93739918c59509 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.69e-05 | 152 | 115 | 5 | 0fda8980b10ce16179dea92301db74d728f41794 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 5.64e-05 | 158 | 115 | 5 | ab05f6d7968ccd6d3826cd71b763dbedc83822c3 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.81e-05 | 159 | 115 | 5 | c0e55f25271f788c08fa4b95186501fc27b2ec39 | |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.34e-05 | 162 | 115 | 5 | c21a54310b239d999bbc9d8fb5e8fda16e0bc336 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.34e-05 | 162 | 115 | 5 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | 368C-Lymphocytic-Plasma_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.34e-05 | 162 | 115 | 5 | f945688815229c8386cbcbf46deee7df316fa8d3 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B_plasma-Plasma_cells|blood / Manually curated celltypes from each tissue | 6.92e-05 | 165 | 115 | 5 | 1c0c24fe252b761cf879b83562e23c02f0b6489f | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.12e-05 | 166 | 115 | 5 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 7.53e-05 | 168 | 115 | 5 | e8bd090de5c9fe286b08a8b314ce12cf988184f0 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 168 | 115 | 5 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-05 | 169 | 115 | 5 | 4ac21e8199de4b6917eacadc56fffc6d886ee643 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 8.42e-05 | 172 | 115 | 5 | 8156fb6de66a4c92ade703b71c2e9187291e50ef | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.42e-05 | 172 | 115 | 5 | 172e3c78f8e97988a4fd8624514e731282ddc16d | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.42e-05 | 172 | 115 | 5 | 5fb0ea6145892a258696197b3feed9760187e712 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.42e-05 | 172 | 115 | 5 | 2214cc37d7c21b868768d3f74ca4631d339d37b3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.42e-05 | 172 | 115 | 5 | 07620728a6cdeea805e1365e588be096c17a370c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.65e-05 | 173 | 115 | 5 | 0ca2169a275404118038c0489a48062879488765 | |
| ToppCell | Plasma_cells|World / lung cells shred on cell class, cell subclass, sample id | 8.65e-05 | 173 | 115 | 5 | 52a387e2a4694af61a9223a4c2ecf4e6f762c064 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.65e-05 | 173 | 115 | 5 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 175 | 115 | 5 | b80fe906043b3cb0b3ba761aadc9dc1c364aa1bf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 175 | 115 | 5 | 067c7d89cfdf6ebf70692df64b9b79d752f093dd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-05 | 177 | 115 | 5 | c2b0fb5921eea24d248d6e6ccb57c29b0832602c | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.63e-05 | 177 | 115 | 5 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.63e-05 | 177 | 115 | 5 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.63e-05 | 177 | 115 | 5 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 | |
| ToppCell | -IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 9.63e-05 | 177 | 115 | 5 | ae2d2e138946535596fa30a55207f261cafda461 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.63e-05 | 177 | 115 | 5 | fc40918825b7e1eb6861df59dfca944778a64b98 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-05 | 177 | 115 | 5 | 111fb0707ff37ca631d85bb5a09e067ffe568eb8 | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|tumor_Lung / Location, Cell class and cell subclass | 9.63e-05 | 177 | 115 | 5 | 37e03f51925345f5f716ef3abe1d2c4ccf129020 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.89e-05 | 178 | 115 | 5 | 6765c6970b1f2b719a20d2afd7471e1c262f3fc4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.89e-05 | 178 | 115 | 5 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.89e-05 | 178 | 115 | 5 | 693f1135d9c5545945e80c7ba3d098afc0ccac29 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 179 | 115 | 5 | 837ed81f18257f444eaeadc4fac89deedd4e3061 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-3|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.02e-04 | 179 | 115 | 5 | f36776299e570345e18dc38cdef4cfc90e7ed7c2 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 179 | 115 | 5 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-04 | 180 | 115 | 5 | cd04d7bf92986a5b8a0193c9b92ec47da3929bac | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 180 | 115 | 5 | e3877f6ef5f54ff689058b4c996ab1851822f871 | |
| ToppCell | cellseq-Immune-Lymphocytic_B|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-04 | 180 | 115 | 5 | 663a800ab70e7ab7d13183417f9c1ed36907aa5e | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 1.07e-04 | 181 | 115 | 5 | 949ac3b60e7fb5968da4c4e872965fb4e10f4a35 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 181 | 115 | 5 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 182 | 115 | 5 | fe4fb213dc0ca482b0f94097fe1b0a51fc2690e2 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.13e-04 | 183 | 115 | 5 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.13e-04 | 183 | 115 | 5 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 185 | 115 | 5 | 0fa7970709dc957dea95fabbd83263a0335babd5 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 185 | 115 | 5 | ae966929fb5bbb08ffcbac76cb21941638727f55 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.19e-04 | 185 | 115 | 5 | 3beebaa92275086b1fae5f8c0c3d54016c5ba2aa | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 185 | 115 | 5 | ceff11cfa679147ccfd0a0f8079e697a6bea34d9 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-04 | 185 | 115 | 5 | 9aea5ed8f9cee5ee933891203aac7adb85d68201 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-04 | 185 | 115 | 5 | 42939b294ea3e871274d8b73124c850dc1904fd2 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-04 | 185 | 115 | 5 | 08bc817908076734d66f2805cb954141f2cc5a18 | |
| ToppCell | Severe_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.19e-04 | 185 | 115 | 5 | f7ef0d7740b4cfedc38846e802898c402dc411fd | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-04 | 185 | 115 | 5 | 1704a12153a9b107bf03ecccd1a036cf61334d7a | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 185 | 115 | 5 | 7a3612520ae4f0cd61480eadba31eecce001419d | |
| ToppCell | COVID-19-lung-Plasmablasts|lung / Disease (COVID-19 only), tissue and cell type | 1.22e-04 | 186 | 115 | 5 | 81caf67da9fed09c77b7ddcab9b0b8e4fab2de97 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.25e-04 | 187 | 115 | 5 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | Mast_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.28e-04 | 188 | 115 | 5 | 229d24b87e945c4d543d11ac70761e45175ba0e5 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.28e-04 | 188 | 115 | 5 | bd53b0371154cff680226897b61c9809a239d1b6 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.28e-04 | 188 | 115 | 5 | c3cae529fdbeb233d2b32bcc3537a8aba26a7dc2 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.28e-04 | 188 | 115 | 5 | 5a89587ee6f2b4dc14244bd88bb31efb81c50dbe | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 189 | 115 | 5 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Late_pre-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 189 | 115 | 5 | 3012e67093ca7c281ee8f1b68064646961f250f9 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 189 | 115 | 5 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.31e-04 | 189 | 115 | 5 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 190 | 115 | 5 | c408d4033a130c0168159a5b6f286fd2b2a9a39d | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 190 | 115 | 5 | d4910c37045a8b8bb53b37625263bc0a47b6e3f8 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 101 | 115 | 4 | 86acaa2502f61baa714ae988b73e3e73a71e897e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 191 | 115 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.41e-04 | 192 | 115 | 5 | 119832d4aee29ddda2485fc3e5dcdaacf833cc30 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-04 | 192 | 115 | 5 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.41e-04 | 192 | 115 | 5 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-04 | 192 | 115 | 5 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 192 | 115 | 5 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| Disease | corpus callosum volume measurement | 2.98e-05 | 100 | 105 | 5 | EFO_0010299 | |
| Disease | cD177 antigen measurement | 3.44e-05 | 18 | 105 | 3 | EFO_0021866 | |
| Disease | nephrolithiasis (implicated_via_orthology) | 1.25e-04 | 5 | 105 | 2 | DOID:585 (implicated_via_orthology) | |
| Disease | corpus callosum central volume measurement | 1.34e-04 | 28 | 105 | 3 | EFO_0010296 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 2.60e-04 | 7 | 105 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | Alzheimer disease, fasting blood glucose measurement | 4.44e-04 | 9 | 105 | 2 | EFO_0004465, MONDO_0004975 | |
| Disease | 3-methyl-2-oxobutyrate measurement | 5.54e-04 | 10 | 105 | 2 | EFO_0021020 | |
| Disease | Cystic Kidney Diseases | 6.76e-04 | 11 | 105 | 2 | C1691228 | |
| Disease | Alzheimer disease, polygenic risk score | 1.19e-03 | 586 | 105 | 8 | EFO_0030082, MONDO_0004975 | |
| Disease | congenital disorder of glycosylation type I (implicated_via_orthology) | 1.28e-03 | 15 | 105 | 2 | DOID:0050570 (implicated_via_orthology) | |
| Disease | anemia (implicated_via_orthology) | 1.28e-03 | 15 | 105 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | PR interval | 1.99e-03 | 495 | 105 | 7 | EFO_0004462 | |
| Disease | Malignant Glioma | 2.02e-03 | 70 | 105 | 3 | C0555198 | |
| Disease | mixed gliomas | 2.02e-03 | 70 | 105 | 3 | C0259783 | |
| Disease | leprosy, Crohn's disease | 2.29e-03 | 20 | 105 | 2 | EFO_0000384, EFO_0001054 | |
| Disease | body weight loss | 2.77e-03 | 22 | 105 | 2 | EFO_0005245 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TIWFTDTSALGHLLN | 81 | Q9NYP8 | |
| LLSLLGQTSSLSWHL | 2141 | Q9HCE0 | |
| HLFTAIQLACLGLLW | 886 | Q96Q91 | |
| HLLLWGKASAELQTL | 306 | Q9UJX5 | |
| LLWFENSLLFSHNAG | 256 | Q86XM0 | |
| GLSTLHLILAWQLNR | 266 | O43306 | |
| LKSSWATGLHLSVLF | 71 | Q9Y574 | |
| LHTLSVSQLLRVFWL | 16 | Q6V0I7 | |
| LWHSFGTIAALLQEI | 56 | Q92600 | |
| LLWEFASRITLHGFI | 176 | Q16854 | |
| WTLGVLFFLLVDTGH | 6 | O95841 | |
| QQSWHTFLLLILFLI | 206 | P32238 | |
| VNTIWFLHLTLADLL | 56 | Q16581 | |
| NIKIWSLSTFGLLHT | 2951 | Q9Y485 | |
| LLHTLAEFGWLLTSV | 361 | Q52LD8 | |
| NSIGISFHSAWLTVL | 346 | P21802 | |
| SWFLSNIIALTHTLL | 161 | Q8NH92 | |
| EFLFLGLTHSWEIQL | 11 | O95013 | |
| GLTHSWEIQLLLLVF | 16 | O95013 | |
| AVAWTLGVSHSLFQL | 146 | O95013 | |
| IFISTWLTAAGFIHL | 306 | Q12791 | |
| LLLTLLAHCTGSWAQ | 6 | A0A075B6I6 | |
| TLGLIWTIILHFQIS | 126 | Q03001 | |
| HGLWNLASLFSNLCL | 106 | Q8WVP7 | |
| AFLTAAIILLHTFWG | 161 | Q96BI3 | |
| HLVSAIGQKIFLWSL | 1181 | Q10570 | |
| LLLTLLAHCTGSWAN | 6 | P01721 | |
| LLLTLLTHCAGSWAQ | 6 | P01700 | |
| LLLTLLIHCTGSWAQ | 6 | P01701 | |
| WLLVALAALGLLAHF | 116 | Q16873 | |
| ILSWIVGIFHALSQL | 146 | Q96R72 | |
| ILSWIIGFLHSISQI | 146 | Q8NH43 | |
| SWLAGFLHSILQTLL | 146 | Q8NGB4 | |
| IKHSFNLLGRLATWL | 291 | Q8TE67 | |
| LWTFLLALGHFLSEL | 81 | Q9UKR5 | |
| SITLSFLSIHLGWNS | 146 | P25021 | |
| LLLTLLTHCAGSWAQ | 6 | P01699 | |
| SVQALLHNSSLWIGL | 1151 | O60449 | |
| LSQGLSLLFLALWHG | 361 | Q6P1A2 | |
| LWSAIGLSIALHVGF | 276 | P06744 | |
| SILLNGLAVWIFFHI | 56 | Q9BY21 | |
| SWFLSNIIALTHTLL | 161 | Q8NGQ3 | |
| LASAHFILAVTLTLW | 6 | P61366 | |
| ALSAFLVLVFLWLHS | 126 | Q9H8P0 | |
| THLLAALAVLLRFWA | 81 | Q8TEZ7 | |
| LLLLFFSHLILSAWA | 6 | P12034 | |
| FGVIHSVFTNLLLWA | 201 | Q7RTM1 | |
| ILHAVALWLNSTGFT | 1531 | Q9P2D3 | |
| GIQFLLLWLVSGSTH | 1086 | P54289 | |
| ALIHSVSDAFSGWLL | 116 | P51795 | |
| CAGLLLSLAQHLWTL | 21 | Q6V0L0 | |
| HGLLSAALQAWALLL | 296 | Q12894 | |
| WLHESTNLLTNFSLG | 61 | P32314 | |
| HLLSFLLLWISDTRA | 6 | P06315 | |
| ALLQLSCTLHWSFLL | 641 | Q8NFI3 | |
| LWGLAIHASKSQFLT | 546 | O00423 | |
| ASWLFGLLAVNHSIL | 2736 | Q9NYQ7 | |
| LLLLGSQILLIYAWH | 16 | Q9H4G1 | |
| GILFATLSCLHIWIL | 101 | P51636 | |
| LRAGWNELLIASFSH | 301 | P19793 | |
| VYGAAWLLLHLQGSS | 181 | Q6NUT3 | |
| QLSAGWLLDHLSFIN | 6 | Q8N3J2 | |
| RLTSVLTLLFSGLWH | 6 | Q8WYK1 | |
| LTLLFSGLWHLGLTA | 11 | Q8WYK1 | |
| AWLGGFLHSLVQLLL | 146 | Q8NH37 | |
| EFLFLGLTHSWEIQL | 11 | Q6IEY1 | |
| GLTHSWEIQLLLLVF | 16 | Q6IEY1 | |
| AVAWTLGVSHSLFQL | 146 | Q6IEY1 | |
| STWLGVFAALHLTAL | 576 | O60391 | |
| FLLLARHLSWSDAIL | 1256 | Q8NET4 | |
| INHFSIWLAASLSIF | 91 | P0DSN6 | |
| WTLRDGAALLLSHIF | 261 | Q9Y6J9 | |
| HWDLLLLAIINTGLS | 681 | Q8NBS3 | |
| ATRLLFLLHSLVGVW | 11 | Q6ZUK4 | |
| LFLLLSTHLGLTLLW | 1111 | A2VEC9 | |
| TALLSAHFLLWQALV | 171 | Q96HE8 | |
| FHQLSQNLLLWLASA | 6666 | Q8WXH0 | |
| LHTTLLLKTLGNHSW | 386 | Q8NDZ6 | |
| NFLHTLSWVLNLFGI | 321 | Q96LT4 | |
| GSLIHGLWNLVFLFS | 106 | Q6UX01 | |
| LLLTLLAHCTGSWAQ | 6 | P01703 | |
| LFWEGQVSLSLLLIH | 181 | Q96DL1 | |
| QHITWKGLLLTASLL | 11 | Q00889 | |
| WEESLTQHVAGLLFL | 201 | Q8NBL3 | |
| AFDSWLSLLLLGDHQ | 101 | Q6ZMB5 | |
| WILVASLAKIGFHLS | 61 | P48764 | |
| HSLVTAAALNGLFWL | 81 | Q8NC44 | |
| IELSLITLHWFLTAF | 271 | Q96HU1 | |
| LLQRLHSLNGSILWI | 226 | Q92186 | |
| TGLLALSFHVLWLIG | 491 | Q8IVJ1 | |
| TALLALSFHFLWLIG | 551 | Q96JW4 | |
| LWHYLFIGTLNSLLT | 291 | Q8NBI5 | |
| GFILALAWFILHSNS | 181 | P03915 | |
| AAAGLVYHWLASLLL | 61 | Q9BR26 | |
| LAVLISGSNWHFIFT | 3816 | P08F94 | |
| ALLHTLHSLTQWNGL | 861 | Q9BVR0 | |
| FLWQHQLLGLLSVYT | 496 | Q6P9B9 | |
| GILLWHVSSQSLSFD | 241 | P08514 | |
| QHITWKGLLLTASLL | 11 | Q13046 | |
| SLLLGTIHALIFAWN | 261 | Q9UHE8 | |
| LLSAWFGHLRILQIL | 96 | Q495B1 | |
| SVLLLWNFGLLIVDH | 146 | Q9BVK2 | |
| SWIILSNLFLHLRAT | 41 | Q8N8G6 | |
| VLEWIHGLSLFLRGS | 86 | Q9HAE3 | |
| IGSHWLQFKLLTEIS | 341 | Q8TCY9 | |
| SLIFLNPTLDHLSFW | 231 | Q5M7Z0 | |
| VTWNQHTSLALLSGL | 531 | Q6ZTK2 | |
| HHSGVFFLQTLLWIL | 16 | P51512 | |
| STLLQRLHLLWAAGQ | 306 | Q9HC29 | |
| LWILLASLAKIGFHL | 86 | Q9UBY0 | |
| SWLLVEGLYLHTLLA | 231 | P47872 | |
| LSFVSVWLLLLLGHS | 101 | P41440 | |
| WFLLLLQGHLHASTT | 1626 | Q6ZS81 | |
| FLANHTNILLASSIW | 76 | Q9NVV0 | |
| TFPSIHLWTRLLSAL | 256 | Q2T9K0 | |
| SFGILIWEILTLGHQ | 2146 | P08922 | |
| IFLLTLWGFHTKLND | 311 | Q9H0V1 | |
| LGLIWTIILHFQISD | 271 | Q15149 | |
| GFLSTLAILVIFWRH | 576 | Q8TE23 | |
| LSLALGWEAFHALQI | 306 | Q8N357 | |
| CVLLLTSAQLGLHIW | 176 | Q9Y5U5 | |
| IILLFHLASLAGSWR | 226 | Q9H330 | |
| HWILLGCFAISLLVS | 131 | Q9NYW2 | |
| QHITWKGLLLTASLL | 11 | Q15238 | |
| HWRIAAGLLFNLLVS | 11 | Q7Z769 | |
| QLLLASGRAHVLWTT | 466 | Q15048 | |
| VSGLLNLSLLYHVWL | 261 | Q9BTX1 |